Long-term Follow-up of MRC Myeloma IX Trial: Survival Outcomes with Bisphosphonate and Thalidomide Treatment - Concepedia

Concepedia

Publication | Open Access

Long-term Follow-up of MRC Myeloma IX Trial: Survival Outcomes with Bisphosphonate and Thalidomide Treatment

DOI Full Paper Access

151

Citations

28

References

2013

Year

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Alexander J. Szubert, Gordon Cook, Mark T. Drayson, Roger G. Owen, Fiona M. Ross, Graham Jackson, J. Anthony Child

Clinical Cancer Research

Abstract

Long-term follow-up is essential to identify clinically meaningful treatment effects in myeloma subgroups based on cytogenetics.

References

	Year	Citations

Page 1